The dramatic rise in worldwide prevalence of obesity has necessitated the search for more efficacious antiobesity strategies to counter the increased cancer risks in overweight and obese individuals. The mechanistic pathways linking obesity status with adult chronic diseases such as cancer remain incompletely understood. A growing body of evidence suggests that novel approaches and interventional agents to disrupt the feed-forward cycle of maternal to offspring obesity transfer that is initiated in utero will be important for stemming both the obesity pandemic and the associated increase in cancer incidence. The convergence of multiple research areas including those encompassing the insulin and insulin-like growth factor systems, epigenetics, and stem cell biology is providing insights into the potential for cancer prevention in adult offspring previously exposed to the intrauterine environment of overweight/obese mothers. Here, we review the current state of this nascent research field, with a focus on three major cancers, namely breast, colorectal, and liver, and suggest some possible future directions to optimize its impact for the health of future generations.
Birth weight and birth length as surrogates of fetal growth and nutrition: links with later obesity and cancer incidence Birth weight and length for infants of normal gestation period has important predictive value for later adult BMI as well as propensity for chronic diseases. High birth weight has been associated with an increased tendency for obesity in later life (Oken and Gillman, 2003) . Low birth weight is associated with increased risk for heart disease, hypertension, type 2 diabetes, and glucose intolerance in adulthood (Barker et al., 2009) . Importantly, birth weight and birth length are positively associated with risk for certain cancers (Andersson et al., 2001; Ahlgren et al., 2007) . Among childhood cancers, birth weight is positively associated with increased risk for neuroblastoma and leukemia (Koifman et al., 2008; Caughey and Michels 2009; Rangel et al., 2010) . Further, the risk of prostate (Eriksson et al., 2007; Cnattingius et al., 2009) and testicular (Michos et al., 2007; Ramlau-Hansen et al., 2009 ) cancers in men is positively associated with birth weight. In contrast, increased risk for colorectal cancers is linked to lower birth length for men, but not women (Nilsen et al., 2005) .
The influence of birth weight on breast cancer risk is not as straightforward, although several recent reports show a modest positive correlation of birth weight (and length) with occurrence of this cancer in adulthood Park et al., 2008; Silva Idos et al., 2008; Maehle et al., 2010) . Women who had lower birth weight but had increased adipose tissue deposition while young had lower breast cancer risk (Baer et al., 2010) . In this regard, the apparent positive associations of birth weight and length with a premenopausal woman's circulating estradiol levels (considered a major risk factor for breast cancer) are intriguing (Jasienska et al., 2006) . However, in another study, premenopausal women with lower than average birth weights who then gained excess weight as adults tended to have elevated serum estrogen concentrations in comparison with women with higher birth weights and excess weight gain as adults (Finstad et al., 2009) . Although it is apparent that birth indices can have long-lasting effects on circulating estradiol levels, the relative contributions of the ovaries, adrenals, and adipose depots to these programmed changes in estradiol synthesis and secretion, with potential impact on breast cancer risk, remain unexplored.
Maternal body mass index and progeny's adiposity
Maternal BMI is positively associated with increased birth weight and neonatal adiposity (HAPO Study Cooperative Research Group, 2010) . A high prepregnancy BMI and/or excessive weight gain during pregnancy confer a propensity for greater adiposity of children born from these mothers (Gillman et al., 2008; Crozier et al., 2010; Fraser et al., 2010; Pirkola et al., 2010) . Children with high BMI often become obese adults (Field et al., 2005; Freedman and Sherry, 2009; Mamun et al., 2009) . The effect of prepregnancy obesity on adiposity status of progeny may be amplified by concurrent gestational diabetes (and insulin resistance) in pregnant mothers (Pirkola et al., 2010; Carmody et al., 2011) . Thus, a positive feed-forward cycle of adiposity transferred from mother to child will in all likelihood increase relative risk for cancers in the latter during adulthood and maybe even earlier ( Fig. 1 ).
Obesity and insulin/insulin-like growth factor systems
The insulin and insulin-like growth factor (IGF) systems are likely important functional links between obesity and increased cancer risk. Of particular note, obesity leads to enhanced circulating levels of insulin, IGF-I, IGF-II, and  IGF-binding protein 3 (IGFBP-3) , while reducing levels of the low-molecular-weight IGFBPs (IGFBP-1 and IGFBP-2) ( Table 1) . The net effect of these changes is increased signaling through the insulin and IGF-I receptors, with resultant increased mitogenesis and decreased apoptosis, in many if not all tissue sites. An elevated circulating level of insulin is a major risk factor for colon, breast, and liver cancers (Table 2) . Similarly, an elevated circulating level of IGF-I and reduced circulating levels of IGFBP-1 and IGFBP-2 are known risk factors for colon cancer ( Table 2 ). The circulating IGF system, as well as pancreatic insulin secretion and tissue insulin sensitivity, are influenced by dietary or obesity effects in utero and/or during lactation (Xiao et al., 2007; Nivoit et al., 2009; Steegers-Theunissen et al., 2009; Tosh et al., 2010) .
Maternal obesity and breast cancer
Pregnancy weight gain may influence risk for breast cancer in mothers and their daughters. For postmenopausal women, excessive weight gain during their prior pregnancies was found to increase risk for development of breast cancer (Kinnunen et al., 2004) . By contrast, a comparable gain in weight may confer short-term protection against premenopausal breast cancer (Hilakivi-Clarke et al., 2005) . Interestingly, BMI, pregnancy weight gain, and dietary fat intake do not appear to significantly affect maternal steroid hormone levels during pregnancy (Kaijser et al., 2002; Faupel-Badger et al., 2009; Lof et al., 2009) . In animal models of mammary carcinogenesis, consumption of a high-fat diet resulted in enhanced pregnancy weight gain and an increase in subsequent mammary cancer incidence . Effects of obesity (and of excessive weight gain) during pregnancy on breast cancer risk of daughter(s) have also been examined, albeit only in limited fashion. Prepregnancy BMI was not associated with breast cancer risk of daughters, whereas a pregnancy weight gain of 25-34 pounds was associated with a slightly increased risk for breast cancer (odds ratio = 1.5; confidence interval = 1.1, 2.0) in daughters (Sanderson et al., 1998) . Paradoxically, women whose mothers gained 35 pounds or more during pregnancy were not at increased risk. Although these associations were based on a limited number of individuals (510 case mothers, 436 control mothers), have not been replicated, and the mechanism(s) underlying this association at the molecular level remain unexplored, the potential consequences of these associations, if confirmed, are highly relevant to the current global obesity pandemic.
The uterine milieu has been shown to affect the offspring's risk for adult breast cancer. For example, the condition of preeclampsia has been associated with protection against breast cancer risk in both mothers and their female offspring (Innes et al., 2005; Vatten et al., 2007; Xue and Michels, 2007) . Pelvic intercristal width in pregnant mothers, which was used as a surrogate for maternal circulating sex steroid hormones, was positively Only those factors that exhibited a statistically significant association with obesity or BMI within a given study are listed. BMI, body mass index; IGF-I, insulin-like growth factor-I; IGF-II, insulin-like growth factor-II; IGFBP-1, insulin-like growth factor-binding protein-1; IGFBP-2, insulinlike growth factor-binding protein-2; IGFBP-3, insulin-like growth factor-binding protein-3. Only those endocrine factors that exhibited a statistically significant and consistent (i.e. over multiple studies) association with specific cancer risk are shown. Some studies reported significant associations of serum insulin-like growth factor (IGF-I), insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-2, and/or IGFBP-3 with premenopausal or postmenopausal breast cancer risk; however, a comparable number of other studies reported a lack of such associations. The liver is the major tissue source of circulating IGF-I and IGFBPs. The relationships of serum IGF-I and IGFBPs with hepatocellular carcinoma risk (and status) are complex, due to the dysregulated expression of these genes in preneoplastic, transformed, or cancerous liver cells.
associated with risk of breast cancers in adult offspring (Barker et al., 2008) . Further, a linkage between higher maternal BMI and elevated cord blood C-peptide levels (HAPO Study Cooperative Research Group, 2010), a stable biomarker of insulin secretion, has been reported. The latter provides a possible route by which maternal BMI may adversely influence the fetus.
Exposure of rats or mice during pregnancy and/or lactation to diets rich in energy, fats, and/or sugars has detrimental health effects in their offspring. These include increased adiposity, hyperglycemia, hyperinsulinemia, triglyceridemia, depressed immune function, altered neural and satiety regulatory pathways, hypertension, reduced plasma antioxidant status, and lower bone mineral density (Bayol et al., 2008; Gupta et al., 2009; Liang et al., 2009; Nivoit et al., 2009; Alzamendi et al., 2010; Bayol et al., 2010; Odaka et al., 2010; Maurer and Reimer, 2011; Sullivan et al., 2011) . Pregnant rats fed a high-fat diet delivered pups with increased birth weight and their female offspring exhibited shortened mammary tumor latency and increased tumor growth when given a mammary carcinogen as young adults . In a similar model of mammary carcinogenesis, offspring of dams fed diets containing a large amount of corn oil as fat source prior to and during pregnancy/ lactation showed increased mammary tumor incidence (Stark et al., 2003) . In contrast, feeding an equivalent amount of olive oil (considered a healthy source of dietary fats) to dams was inhibitory to tumor formation in their progeny. These latter studies highlight the value of dietary lipid composition (good vs. bad fats) in the inutero programming of breast cancer.
Maternal obesity and colorectal cancers
Overweight and obesity are positively associated with increased colorectal cancer risk in men and to a lesser degree in women (Frezza et al., 2006; Dai et al., 2007; Kim et al., 2007; Nock et al., 2008; Thygesen et al., 2008) . The positive linkage between colon cancer mortality and obesity is also more evident in men than in women (Murphy et al., 2000) . Similar findings were observed in rat (Newberne et al., 1990; Weber et al., 2000; Koch et al., 2008) and mouse (Yakar et al., 2006; Gravaghi et al., 2008) models. In obese animals, colon tumor genesis was correlated with elevations in serum insulin, leptin, glucose, triglycerides, and cholesterol. However, proof of causality for any of these factors, individually or together, remains lacking.
Several studies have probed the developmental influences of underweight, overweight, and obesity in children on their subsequent risk for colorectal cancer. Exposure to energy restriction during childhood and adolescence (Dutch famine years of World War II) was associated with reduced risk of colorectal cancer later in life (Hughes et al., 2009) , presumably reflecting metabolic programming and/or an epigenetic phenomenon. High BMI (i.e. above the 85th percentile of a US reference population) at adolescence (i.e. 14-19 years of age) was positively associated with increased risk of death (relative risk of 2.1 and 2.0 for males and females, respectively) from colorectal cancers in later life (Bjørge et al., 2008) . Interestingly, a recent study showed that colon cancer risk in men is highly influenced by less drastic weight gains (Thygesen et al., 2008) . In their study, Thygesen et al. (2008) reported that a cumulative mean BMI above 22.5 conferred increased colon cancer risk. Weight gain (1 lb/year) beginning at the age of 21 years was associated with an increased cancer risk (Thygesen et al., 2008 ). Short-term (2-4 years prior) weight gain of 10 lbs was positively associated with cancer risk in the proximal half of the colon (Thygesen et al., 2008) . The rise in propensity for colon cancer with long-term weight gains was demonstrated in a study of African-American women (Wise et al., 2008) . In this case, a weight gain of 30 kg or more beginning at the age of 18 years was positively associated with risk for colorectal polyps. Animal studies also support the influence of early postnatal weight gain on colon cancer incidence. Early overfeeding of preweanling rats enhanced colon tumorigenic capability later in life (Newberne et al., 1990) . In a rat model of intestinal carcinogenesis, switching of pregnant rat dams from a nonobesogenic diet to a more obesogenic diet at parturition accelerated early neonatal body weight accretion, increased colon tumor multiplicity, and altered circulating levels of IGF system components in male progeny as later adults (Xiao et al., 2007) . However, no studies (using human populations or animals) have yet evaluated the role of maternal obesity on the progeny's colon cancer risk at later adulthood.
Maternal obesity and hepatocellular carcinoma
Obesity leads to an increased propensity for liver cancers in humans (Oh et al., 2005; Samanic et al., 2006; Ioannou et al., 2007; Donadon et al., 2008) . Feeding a 'Western' or 'cafeteria' diet rich in fats and sugars to pregnant and lactating rats promoted hepatic steatosis and liver oxidative stress response in their progeny (Bayol et al., 2010) . The steatosis and oxidative stress are well-known promoters of the liver pathology that precedes hepatocellular carcinoma (Ha et al., 2010) . Thus, it is tempting to speculate that the rising incidence of liver cancer in the United States and other western societies (associated with increased rates of hepatitis virus infection) is further fueled, in part, by maternal obesity. However, to the best of our knowledge, no studies have directly examined this possibility.
Maternal obesity and the fetal/neonatal epigenome
Effects of diet and nutrition can be transgenerational. Chronic consumption of high-fat diets by young female rats conferred glucose intolerance, hyperinsulinemia, triglyceridemia, and increased adiposity to their male progeny, indicating long-term, programmed, and heritable alterations in metabolism, gene expression, and tissue phenotype (Srinivasan et al., 2006) . Feeding a high carbohydrate diet to female rat pups around weaning led to hyperinsulinemia and increased adiposity later in life; effects they transmitted to their progeny (Patel and Srinivasan, 2010) . Similarly, consumption of a high-fat diet for 4 weeks by dams from prepregnancy through to weaning induced a heritable increase in body length and a decrease in insulin sensitivity in first-generation and second-generation rat offspring (Dunn and Bale, 2009 ). Most interestingly, these transgenerational effects were propagated via maternal and paternal lineages, indeed supporting an epigenetic basis (Dunn and Bale, 2009 ).
The long-term contributions of maternal diet to adult offspring health have been postulated to also involve altered stem cell numbers and/or rates of stem cell renewal (Eden, 2010; Capittini et al., 2011) . To date, only a few known links between nutrition, insulin and IGF systems, and stem cell renewal have been defined (Drummond-Barbosa and Spradling, 2001; Baik et al., 2005; Kakarala et al., 2010) . Although the relevance of insulin as an essential factor for in-vitro sphere-forming ability (a measure of cancer stem cell renewal) of multiple cancer stem cell types is compelling, given this factor's mitogenic action, further studies are required to mechanistically explain these connections.
With increased interest in the role that epigenetics plays in disease evolution, studies seeking to understand whether, and how, maternal obesity (and maternal diet) affects the epigenome of the fetus and neonate and in so doing, modifies disease susceptibility at later adulthood have grown in numbers within the last several years. Initial studies have focused on rat liver metabolic and metabolism-regulatory genes to model dietary influences involving the epigenome in the impairment of developmental processes in progeny. Dietary protein restriction and folic acid supplementation in pregnant rats were found to elicit specific changes in DNA methylation of liver glucocorticoid receptor and peroxisomal proliferatoractivated receptor-a genes in progeny, correlating with respective levels of expression (Lillycrop et al., 2005 (Lillycrop et al., , 2007 (Lillycrop et al., , 2008 . Importantly, both of these nuclear receptors are key players in metabolic regulation of the liver. In a study of intrauterine growth-restricted rat fetuses, altered histone methylation status of the liver IGF-I gene was associated with corresponding modifications in hepatic IGF-I expression and deregulated metabolic status (Tosh et al., 2010) . Remarkably, a high-fat diet fed to male rats programmed pancreas b-cell dysfunction as well as hypomethylation of a specific pancreatic islet gene in their female progeny (Ng et al., 2010) . Neonatal overfeeding, through litter size restriction, led to increased methylation of the insulin receptor gene promoter in adult rat hypothalamus . Such phenomena are not restricted to rodents. A recent study of pregnant women found that maternal folic acid supplementation during pregnancy correlated with increased DNA methylation of the IGF-II gene differentially methylated region in their children at the age of 1 1 = 2 years (Steegers-Theunissen et al., 2009) . Most significantly, an inverse association between extent of IGF-II gene differentially methylated region methylation and birth weight was described. Although none of the above studies specifically examined for effects of maternal obesity or overweight on epigenetic phenomena in progeny, they do provide impetus for further investigations in this direction.
To comprehensively address the contribution of the maternal environment, fetal stem cells and the fetal epigenome to the etiology of breast cancer, the epigenetic program of mammary gland development, and functional differentiation, was recently elucidated (Rijnkels et al., 2010) . This information will provide an initial roadmap into understanding how the in-utero and immediate postnatal environments (and interactions with maternal obesity phenotype) modify the mammary gland epigenome as well as this organ's predisposition to, or protection from, tumorigenesis in adult progeny. Similar strategies will invariably prove useful for other tissues subject to fetal programming and high cancer incidence such as the liver, colon, and uterus. The ultimate goal of such studies is to enable reversal of in-utero-instigated epigenetic events (i.e. silencing of tumor suppressive genes and pathways) that contribute to tumor initiation and progression (Hilakivi-Clarke and De Assis, 2006; Delage and Dashwood, 2008; Godman et al., 2008; Davidson et al., 2009) .
Need for new metabolism-based screening paradigms for cancer predisposition
It is now recognized that a greater than average weight gain during the first years of postnatal life is positively associated with obesity and insulin resistance later in life (Oken and Gillman, 2003; Field et al., 2005; Gillman et al., 2008; Larnkjaer et al., 2010) , thereby also leading to increased cancer risk. Weight gains from 0 to 3 months of age were negatively associated with serum ghrelin and adiponectin when corrected for body fat at the age of 17 years (Larnkjaer et al., 2010) . Children born from mothers with type 1 diabetes exhibit increased frequency of overweight/obesity, and the BMI of their children were found to be positively correlated with cord blood leptin, albeit not with insulin levels (Lindsay et al., 2010) . Moreover, daughters born from mothers who had gestational diabetes mellitus and impaired glucose tolerance during pregnancy had increased waist circumference and increased insulin resistance at the age of 15 years (Egeland and Meltzer, 2010) . These findings point to the utility of screening paradigms for children born from overweight, obese, or gestational diabetic mothers to estimate predisposition for adiposity and associated comorbidities. Such screens could include indices of
The in-utero origins of obesity and cancer Simmen and Simmen 543 rates of weight gain, adiposity, adipose-related serum hormones, and insulin sensitivity/resistance during early childhood. Screening could be coupled with nutritional or other preventive interventions such as changes in lifestyle and increased physical activity.
Interventions prior to and during pregnancy
Dietary interventions prior to and during pregnancy may confer some degree of protection against the programming effects of maternal obesity status (Gallou-Kabani et al., 2007) . Indeed, an increased understanding of the maternal influence on health status of progeny has led to current goals to reduce weight gain prior to and during pregnancy for obese/overweight women and to control hyperglycemia in mother and fetus. The newly revised Institute of Medicine Guidelines (http://www.iom. edu/Reports/2009/Weight-Gain-During-Pregnancy-Reexamining-the-Guidelines.aspx) call for less overall body weight gain during gestation for overweight and obese women. Nonetheless, there is a dearth of understanding, borne from a lack of science, of how children's cancer risk is influenced by the mother's BMI at periconception and pregnancy. In addition, the relative contribution, if any, of paternal overweight and obesity status during the periconceptual period to an offspring's cancer risk is unknown. These are important questions, ripe for elucidation using new highthroughput methodologies.
Several hypoglycemic agents that potentially are useful (in combination with diet) during preconception and pregnancy to mitigate the negative effects of maternal obesity include metformin, glyburides, and glucagon-like peptide analogs (Rowan et al., 2008; Dhulkotia et al., 2010; Rowan et al., 2010; Shyangdan et al., 2010; Simmons, 2010; Waugh et al., 2010) . Metformin, in particular, has recently been associated with reduced cancer incidence of multiple tissue sites (including breast, colon, and liver) in diabetic individuals (Currie et al., 2009; Donadon et al., 2009; Bodmer et al., 2010; Hosono et al., 2010; Pollak, 2010; Monami et al., 2011) . Although actively investigated as a treatment for gestational diabetes, to our knowledge, no studies have examined the efficacy of metformin during pregnancy to prevent cancers in progeny (either animal or human studies). The 'promise' of metformin in prevention of cancer programming is highlighted by its ability to traverse the placenta and its lack of teratogenic activity for the human fetus (Eyal et al., 2010) .
Maternal obesity and high fat/high calorie maternal diets impose a proinflammatory state on the fetus (Bouanane et al., 2009; Heerwagen et al., 2010) . In a study of pregnant rat dams, supplementation of a high-fat diet with the antioxidant (and dietary factor) quercetin partially reversed the metabolic syndrome phenotype in progeny (Liang et al., 2009 ). This remarkable result raises the possibility that antioxidant-enriched maternal diets could be used to favorably affect an offspring's cancer risk.
Although there are only few preclinical studies that directly address this potential, there are many dietary phytochemicals with known antioxidant properties and which also exhibit in-vivo bioavailability and in-vitro or invivo cancer-inhibiting actions; examples include quercetin, lycopene, resveratrol, anthocyanin(s), curcumin, silymarin, and catechins (Bisht et al., 2010) . Diets enriched for these factors, and perhaps used in combination with metformin, may provide benefits to expectant mothers who are obese. As some of these same bioactive factors appear to be modifiers of the epigenome, the elucidation of their influence on the expression and activity of chromatin-modifying enzymes may provide insights into their potential cancer-inhibitory actions in offspring (Li and Tollefsbol, 2010; Link et al., 2010) . The feasibility of this approach for minimizing susceptibility to cancer and other adult-onset chronic diseases clearly necessitates preclinical studies in rodent models of maternal obesity.
Cancer risk, both in the immediate and the longer term, is potentially modifiable by nutritional means (Ronco et al., 2010) . A striking example of this is the observation that soyfood consumption during childhood and adolescence lowers breast cancer risk in females during later adulthood (Shu et al., 2001; Wu et al., 2002) . Indeed, a soy protein-based diet fed only during gestation delayed the first appearance of tumor, decreased tumor multiplicity, and inhibited tumor grade in female rat progeny given a mammary carcinogen, when compared with control animals (Su et al., 2007) . Similarly, a maternal (gestation/lactation) diet containing a soy protein isolate resulted in significant reductions in body weight, mammary terminal end bud number, abdominal fat pad weight, and enhanced mammary gland differentiation in female weanling rats, compared with a control maternal diet (Su et al., 2009) . A maternal (gestation plus lactation period) diet containing blueberry powder (a rich source of anthocyanins and polyphenols with demonstrated antioxidant activities) enhanced mammary epithelial differentiation in weanling rats, an effect that may indicate tumor-protective actions in later life (Wu et al., 2009 ). Lastly, a recent report demonstrated significant improvement in glucose tolerance for 6-month-old mice whose dams received a soy protein-based diet from preconception and throughout pregnancy (Cederroth and Nef, 2009 ). These studies provide strong rationale for further development of specific dietary formulations for pregnant obese/overweight mothers with the goal of reducing the potential for cancers in their offspring as adults (Lagiou et al., 2006) . Lastly, given the reports that breast-feeding may confer a lower risk of overweight/obesity for children born of obese mothers (Li et al., 2005) , the question of whether the risk of adult disease in progeny may differ with maternal BMI status during pregnancy and lactation in breast-feeding mothers warrants further scrutiny.
Perspectives
Emerging data predict a positive impact of antiobesity strategies for children on decreasing their long-term cancer risk (Fuemmeler et al., 2009) . However, most current strategies do not consider targeting obesity risk beginning in the womb for the dual prevention of obesity and cancer. Data summarized above demonstrate the maternal contributions to determining an offspring's relative risks for obesity and attendant cancer risk (Fig. 1) . Intervening in the feed-forward cycle of maternal to offspring adiposity/ obesity with new strategies and approaches will be required to stem the obesity pandemic. Given the increasingly acknowledged link between obesity and many cancers, such approaches may also counter the expected rise in occurrence of cancers in children and adults born from overweight or obese mothers. The fields of epigenetics and stem cells will undoubtedly be important in addressing the large gaps in our understanding of the mechanistic aspects of fetal programming of adult cancers and specifically as influenced by maternal obesity and/or maternal diet. Mature fields such as epidemiology, the study of bioactive dietary factors, and the molecular endocrinology of insulin and IGFs also will find application to the above challenges. As many aspects of embryomaternal interaction, placentation, fetal organ system development, and pregnancy are species-specific, it will be important to study multiple animal models as well as primates and the human where appropriate, to elucidate the generalities of maternal obesity effects on a fetus/ neonate's later cancer risk and how this may be countered by targeting the pregnant uterus.
